What is the projected market valuation for the US 3D cell-culture market by 2035?

The projected market valuation for the US 3D cell-culture market by 2035 is $1935.48 Million. Read More

What was the overall market valuation of the US 3D cell-culture market in 2024?

The overall market valuation of the US 3D cell-culture market in 2024 was $626.4 Million. Read More

What is the expected CAGR for the US 3D cell-culture market during the forecast period 2025 - 2035?

The expected CAGR for the US 3D cell-culture market during the forecast period 2025 - 2035 is 10.8%. Read More

Which application segment had the highest valuation in the US 3D cell-culture market?

The Drug Discovery application segment had the highest valuation, reaching $570.0 Million. Read More

What are the key players in the US 3D cell-culture market?

Key players in the US 3D cell-culture market include Thermo Fisher Scientific, Corning, Merck KGaA, and Lonza Group. Read More

Which technique segment is projected to grow the most in the US 3D cell-culture market?

The Bioreactor Systems technique segment is projected to grow the most, with a valuation of $775.48 Million. Read More

What is the valuation range for the Toxicology Testing application segment?

The valuation range for the Toxicology Testing application segment is $150.0 Million to $450.0 Million. Read More

How does the valuation of the Organ-on-a-Chip technique segment compare to others?

The Organ-on-a-Chip technique segment has a valuation range of $120.0 Million to $380.0 Million, indicating moderate growth potential. Read More

What is the expected valuation for the Services product segment by 2035?

The expected valuation for the Services product segment by 2035 is projected to reach $535.48 Million. Read More

Which end-use segment is anticipated to have the highest growth in the US 3D cell-culture market?

The Pharmaceutical Companies end-use segment is anticipated to have the highest growth, with a valuation range of $200.0 Million to $600.0 Million. Read More

US 3D Cell Culture Market

ID: MRFR/LS/13112-HCR

128 Pages

Vikita Thakur

Last Updated: May 04, 2026

United States 3D Cell Culture Market Research Report: Size, Share, Trend Analysis By Product (Scaffold-based 3D Cell Cultures, Scaffold-free 3D Cell Cultures, Microfluidics-based 3D Cell Cultures, and Magnetic & Bioprinted 3D Cell Cultures), By Applications (Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing, and Tissue Engineering & Regenerative Medicine), By End Users (Pharmaceutical & Biotechnology Companies, Research Institutes, Cosmetics Industry, and Other End Users), - United States Market Forecast Till 2035

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Chemicals and Materials, BY Application (USD Million) | |
  1. 4.1.1 Drug Discovery | |
  2. 4.1.2 Toxicology Testing | |
  3. 4.1.3 Regenerative Medicine | |
  4. 4.1.4 Cancer Research |
2. 4.2 Chemicals and Materials, BY Technique (USD Million) | |
  1. 4.2.1 Spheroid Culture | |
  2. 4.2.2 Organ-on-a-Chip | |
  3. 4.2.3 Microfluidics | |
  4. 4.2.4 Bioreactor Systems |
3. 4.3 Chemicals and Materials, BY End Use (USD Million) | |
  1. 4.3.1 Pharmaceutical Companies | |
  2. 4.3.2 Biotechnology Companies | |
  3. 4.3.3 Academic Research Institutes | |
  4. 4.3.4 CROs |
4. 4.4 Chemicals and Materials, BY Product (USD Million) | |
  1. 4.4.1 Reagents | |
  2. 4.4.2 Instruments | |
  3. 4.4.3 Services 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Thermo Fisher Scientific (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Corning (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Merck KGaA (DE) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Lonza Group (CH) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 3D Biotek (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 ReproCELL (JP) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 TissUse (DE) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 InSphero (CH) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 US MARKET ANALYSIS BY APPLICATION |
6. 6.3 US MARKET ANALYSIS BY TECHNIQUE |
7. 6.4 US MARKET ANALYSIS BY END USE |
8. 6.5 US MARKET ANALYSIS BY PRODUCT |
9. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS |
10. 6.7 RESEARCH PROCESS OF MRFR |
11. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS |
12. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS |
13. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS |
14. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS |
15. 6.12 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE) |
16. 6.13 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Million) |
17. 6.14 CHEMICALS AND MATERIALS, BY TECHNIQUE, 2024 (% SHARE) |
18. 6.15 CHEMICALS AND MATERIALS, BY TECHNIQUE, 2024 TO 2035 (USD Million) |
19. 6.16 CHEMICALS AND MATERIALS, BY END USE, 2024 (% SHARE) |
20. 6.17 CHEMICALS AND MATERIALS, BY END USE, 2024 TO 2035 (USD Million) |
21. 6.18 CHEMICALS AND MATERIALS, BY PRODUCT, 2024 (% SHARE) |
22. 6.19 CHEMICALS AND MATERIALS, BY PRODUCT, 2024 TO 2035 (USD Million) |
23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
24. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
25. 7.2 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.2.2 BY TECHNIQUE, 2025-2035 (USD Million) | |
  3. 7.2.3 BY END USE, 2025-2035 (USD Million) | |
  4. 7.2.4 BY PRODUCT, 2025-2035 (USD Million) |
26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
27. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

US Chemicals and Materials Market Segmentation

Chemicals and Materials By Application (USD Million, 2025-2035)

Drug Discovery
Toxicology Testing
Regenerative Medicine
Cancer Research

Chemicals and Materials By Technique (USD Million, 2025-2035)

Spheroid Culture
Organ-on-a-Chip
Microfluidics
Bioreactor Systems

Chemicals and Materials By End Use (USD Million, 2025-2035)

Pharmaceutical Companies
Biotechnology Companies
Academic Research Institutes
CROs

Chemicals and Materials By Product (USD Million, 2025-2035)

Reagents
Instruments
Services

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓